Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 15, 2022 08:00 ET | Source: Waypoint Orthopedics, Inc.

Waypoint Orthopedics Submits 510(k) Application for Waypoint GPS™

MALVERN, Pa., July 15, 2022 (GLOBE NEWSWIRE) -- Waypoint Orthopedics, Inc., a spinal instrumentation company, announced the company's recent submission of an FDA 510(k) application for the Waypoint...
January 08, 2021 08:30 ET | Source: Daxor Corporation

Daxor to Present at the Inaugural H.C. Wainwright BioConnect 2021 Conference

NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology (organized as an investment company with fully-owned...
November 19, 2020 08:30 ET | Source: Daxor Corporation

THIRD HOSPITAL JOINS MULTICENTER COVID-19 BVA-100® BLOOD TEST STUDY

NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
October 29, 2020 08:30 ET | Source: Daxor Corporation

OREGON HEALTH & SCIENCE UNIVERSITY JOINS MULTICENTER COVID-19 BVA-100® STUDY

COVID-19 Investigation Continues at OHSU to Study Hospitalized Patients Utilizing Daxor’s Blood Volume Analysis Technology NEW YORK, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT:...
October 02, 2020 08:30 ET | Source: Daxor Corporation

New Data Released from the Mayo Clinic Utilizing Daxor’s BVA-100® Test Highlights Value of Daxor’s Diagnostic at the Heart Failure Society of America Virtual Annual Scientific Meeting 2020

NEW YORK, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
September 28, 2020 08:30 ET | Source: Daxor Corporation

Daxor Corporation to Exhibit and Showcase Compelling New Data at the Heart Failure Society of America Virtual Annual Scientific Meeting 2020 on the Value of BVA-100®

NEW YORK, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
September 15, 2020 08:30 ET | Source: Daxor Corporation

Daxor to Present at the Inaugural Sepsis Alliance Summit

NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
August 31, 2020 08:30 ET | Source: Daxor Corporation

Daxor Corporation to Present at the LD 500 Virtual Investor Conference

NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
July 08, 2020 08:00 ET | Source: Daxor Corporation

DAXOR ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH AMERICAN MEDICAL DEPOT GOVERNMENT DISTRIBUTOR

NEW YORK, July 08, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
May 22, 2020 08:00 ET | Source: Daxor Corporation

Daxor’s BVA-100® Published in Novel Study in American Heart Association Journal - Circulation

NEW YORK, May 22, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...

Next Page keyboard_arrow_right